3-(sec-Butyl)-5-((3-(4-(isopentyloxy)phenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one

Catalog No. :
ACUZWC781
CAS No. :
623933-05-1
Molecular Formula :
C28H31N3O2S2
Molecular Weight :
505.71

IUPAC Name:(Z)-3-(sec-butyl)-5-((3-(4-(isopentyloxy)phenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one

3-(sec-Butyl)-5-((3-(4-(isopentyloxy)phenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(sec-Butyl)-5-((3-(4-(isopentyloxy)phenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one
IUPAC Name(Z)-3-(sec-butyl)-5-((3-(4-(isopentyloxy)phenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one
Molecular FormulaC28H31N3O2S2
Molecular Weight505.71
SMILESO=C1N(C(C)CC)C(S/C1=C\C2=CN(C3=CC=CC=C3)N=C2C4=CC=C(OCCC(C)C)C=C4)=S
InChI KeyXLDCWXNKWRQCFP-UQQQWYQISA-N
SynonymSALOR-INT L429279-1EA;(5Z)-3-SEC-BUTYL-5-((3-[4-(ISOPENTYLOXY)PHENYL]-1-PHENYL-1H-PYRAZOL-4-YL)METHYLENE)-2-THIOXO-1,3-THIAZOLIDIN-4-ONE;4-Thiazolidinone, 5-[[3-[4-(3-methylbutoxy)phenyl]-1-phenyl-1H-pyrazol-4-yl]methylene]-3-(1-methylpropyl)-2-thioxo-
CAS No.623933-05-1

Synthetic Route by SureRoute

1. ACUZWC781 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUZWC781 route product structure diagram
    ACUZWC781623933-05-1
Inquiry

2. ACUZWC781 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUZWC781 route product structure diagram
    ACUZWC781623933-05-1
Inquiry

Comments (0)